AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

ANZ bank staff worried about restructure 'conversations'
Economy

ANZ bank staff worried about restructure 'conversations'

As ANZ confronts 'Nuno-geddon', ANZ NZ says it's business as usual over here.

Small Cap Wrap: It's all about AGMs
Markets

Small Cap Wrap: It's all about AGMs

Burger Fuel's covid hangover and court costs, Third Age, Solution Dynamics, and more.

‘Pretty big beat’: Hallenstein Glasson impresses
Retail

‘Pretty big beat’: Hallenstein Glasson impresses

Hallenstein Glasson’s profit range beat Forsyth Barr forecasts by 15%.

Me Today sets its sights on UAE
Markets

Me Today sets its sights on UAE

Outside of China and NZ, other priority markets are Japan, the US and Ireland.